Evaluating the Safety Profile of Semaglutide: An Updated Meta-Analysis

• Main Authors: Rivera, Frederick Berro, Arias-Aguirre, Eloise, Aguirre, Zedrick, Ybañez, Mc John C., Rubia, Janos Marc M., Galang, Danica Janine, Lumbang, Grace Nooriza, Ruyeras, Jade Monica Marie J., Magalong, John Vincent, Pine, Polyn Luz, Amigo, John Andrew C., Ansay, Marie Francesca M., Zelenkov, Nenad, Thomas, Steve Samuel, Vijayaraghavan, Krishnaswami
• 格式: text
• 出版: Archīum Ateneo 2024
• 主題: adverse events; glucagon-like peptide-1 receptor agonist; meta-analysis; obesity; safety profile; Semaglutide; type 2 diabetes mellitus; Diseases; Endocrine System Diseases; Medicine and Health Sciences
• 在線閱讀: https://archium.ateneo.edu/asmph-pubs/245; https://doi.org/10.1080/03007995.2024.2383731

Background Semaglutide is increasingly used in the management of type 2 diabetes mellitus and obesity. Ensuring the safety of this medication is crucial for its clinical use. This meta-analysis evaluates the safety profile of semaglutide across patient populations and treatment durations. Methods R...